Good morning, Boston. Spring training has begun, and here are the five things you need to know, including Biogen cutbacks, CVS's new CEO, Eastern Nazarene sale, spring training, Rat Day, and more Vale ...
Foulkes is a self-proclaimed “math geek” and built her career on developing data-driven initiatives at CVS, like the ExtraCare reward card ... growth for CVS Caremark,” said Foulkes.
CVS Caremark started in April 2024 ... may make it more difficult for Stelara biosimilars to compete with the brand-name drug as the calling card of any biosimilars is its lower price with relative to ...
“They’re basically your insurance card when you come into the pharmacy ... for rebates from major drug companies. CareMark, owned by CVS; Express Scripts, owned by Cigna; and United ...
Just as Andrew Witty of UnitedHealth Group did in a call with investors last month, CVS Health’s CEO David Joyner defended ...
A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits ...
Pharmacies across Oklahoma say they are losing hundreds of thousands of dollars because they say a company, CVS Caremark, is supposed to reimburse them for prescriptions and isn't holding up their end ...
CVS Health (CVS) on Tuesday announced the launch of the CVS Health app. The app, a successor to the CVS Pharmacy app and one of many ...
Leerink analyst Michael Cherny upgraded CVS Health (CVS) to Outperform from Market Perform with a price target of $75, up from $55. The firm ...
FTC’s report focused on three largest PBMs: CVS Health Corporation’s CVS Caremark, The Cigna Group’s CI Express Scripts, and UnitedHealth Group Incorporated’s UNH Optum Rx. This report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results